Related references
Note: Only part of the references are listed.FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis
Hamza M. Al-Tamari et al.
EMBO MOLECULAR MEDICINE (2018)
Research review on the pharmacological effects of astragaloside IV
Lei Li et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2017)
Idiopathic pulmonary fibrosis
Luca Richeldi et al.
LANCET (2017)
Epithelial-to-mesenchymal transition and its role in EGFR-mutant lung adenocarcinoma and idiopathic pulmonary fibrosis
Yuji Sakuma
PATHOLOGY INTERNATIONAL (2017)
GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGF β1/Smad-Mediated Epithelial-to-Mesenchymal Transition
Xiao-Ming Zhou et al.
FRONTIERS IN PHARMACOLOGY (2017)
Astragaloside IV Improves Bleomycin-Induced Pulmonary Fibrosis in Rats by Attenuating Extracellular Matrix Deposition
Liu-Cheng Li et al.
FRONTIERS IN PHARMACOLOGY (2017)
lncRNA H19 is involved in TGF-β1-induced epithelial to mesenchymal transition in bovine epithelial cells through PI3K/AKT Signaling Pathway
Wei Yang et al.
PEERJ (2017)
Amelioration of bleomycin-induced pulmonary fibrosis by chlorogenic acid through endoplasmic reticulum stress inhibition
Yi-Chun Wang et al.
APOPTOSIS (2017)
Idiopathic interstitial pneumonias with connective tissue diseases features: A review
Vincent Cottin
RESPIROLOGY (2016)
TGF-β-induced phosphorylation of Akt and Foxo transcription factors negatively regulates induced regulatory T cell differentiation
Yutaka Kurebayashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2
Xiang Chen et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2016)
Inhibitory Effects of Astragaloside IV on Bleomycin-Induced Pulmonary Fibrosis in Rats Via Attenuation of Oxidative Stress and Inflammation
Wei-Na Yu et al.
INFLAMMATION (2016)
Effects of Astragaloside IV Against the TGF-β1-Induced Epithelial-to-Mesenchymal Transition in Peritoneal Mesothelial Cells by Promoting Smad 7 Expression
Lu Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro
Li Wang et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2014)
Tempol Attenuates Renal Fibrosis in Mice with Unilateral Ureteral Obstruction: The Role of PI3K-Akt-FoxO3a Signaling
Hye Eun Yoon et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Melatonin Inhibits Endoplasmic Reticulum Stress and Epithelial-Mesenchymal Transition during Bleomycin-Induced Pulmonary Fibrosis in Mice
Hui Zhao et al.
PLOS ONE (2014)
Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
Weijia Xu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Pathogenesis of Idiopathic Pulmonary Fibrosis
Paul J. Wolters et al.
Annual Review of Pathology-Mechanisms of Disease (2013)
FoxO3a (Forkhead Box O3a) Deficiency Protects Idiopathic Pulmonary Fibrosis (IPF) Fibroblasts from Type I Polymerized Collagen Matrix-Induced Apoptosis via Caveolin-1 (cav-1) and Fas
Richard Seonghun Nho et al.
PLOS ONE (2013)
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
Brett Ley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis
Harold A. Chapman
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Forkhead Homeobox Type O Transcription Factors in the Responses to Oxidative Stress
Peter Storz
ANTIOXIDANTS & REDOX SIGNALING (2011)
Idiopathic pulmonary fibrosis
Talmadge E. King et al.
LANCET (2011)
Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis
Libo Zhao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Contribution of Epithelial-derived Fibroblasts to Bleomycin-induced Lung Fibrosis
Harikrishna Tanjore et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling
Narayanan Sriram et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2009)
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
Antje Moeller et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts
Calin B. Chiribau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR
Stephan Sauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA
Matt K. Lee et al.
EMBO JOURNAL (2007)
The myofibroblast - One function, multiple origins
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: Autocrine mechanisms in myofibroblasts and macrophages
Bruce D. Uhal et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease
Brigham C. Willis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT) -: art. no. 56
H Kasai et al.
RESPIRATORY RESEARCH (2005)
Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-ß1 -: Potential role in idiopathic pulmonary fibrosis
BC Willis et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Share Paper
